000 | 01007 a2200277 4500 | ||
---|---|---|---|
005 | 20250513164215.0 | ||
264 | 0 | _c19990429 | |
008 | 199904s 0 0 eng d | ||
022 | _a0277-6715 | ||
024 | 7 |
_a10.1002/(sici)1097-0258(19990115)18:1<107::aid-sim965>3.0.co;2-p _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFlandre, P | |
245 | 0 | 0 |
_aEstimating the proportion of treatment effect explained by a surrogate marker. _h[electronic resource] |
260 |
_bStatistics in medicine _cJan 1999 |
||
300 |
_a107-9 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aZidovudine _xpharmacology |
700 | 1 | _aSaidi, Y | |
773 | 0 |
_tStatistics in medicine _gvol. 18 _gno. 1 _gp. 107-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1097-0258(19990115)18:1<107::aid-sim965>3.0.co;2-p _zAvailable from publisher's website |
999 |
_c9952093 _d9952093 |